shortagewatch

Home / Cancer and immune system / Ustekinumab

ATC L04AC05 · Immunosuppressants

Ustekinumab shortage

As of 31 Oct 2026, Ustekinumab has a reported shortage in 3 of the 5 countries we track (Italy, Spain, Belgium), covering 9 products.

Countries3/5
Products9packs or presentations
Short since1 Oct 202513 months ago
Earliest return30 Nov 2026company estimate
No return date4products
Main reasonOther
GermanyNo reported shortageItaly3 packs shortSpain2 packs shortAustriaNo reported shortageBelgium4 packs short

Timeline

ItalySpainBelgium
202620272028PYZCHIVAPYZCHIVAPYZCHIVAPYZCHIVAIMULDOSAIMULDOSAIMULDOSA 130 MG CONCENTRADO PARA SOLUCION PAIMULDOSA 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 26 mlSTEQEYMA 45 MG SOLUCION INYECTABLE EN JERINGSTEQEYMA 45 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,5 mlUsymro 45 mg inj. sol. s.c. pre-filled syr. Usymro 45 mg inj. sol. s.c. pre-filled syr. 0.5 mlUsymro 90 mg inj. sol. s.c. pre-filled syr. Usymro 90 mg inj. sol. s.c. pre-filled syr. 1 mlImuldosa 130 mg inf. sol. (conc.) i.v. vial Imuldosa 130 mg inf. sol. (conc.) i.v. vial 26 mlYesintek 90 mg inj. sol. s.c. pre-filled penYesintek 90 mg inj. sol. s.c. pre-filled pen 1 mltoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITPYZCHIVASAMSUNG BIOEPIS NL B.V.1 Oct 2025not givenIncreased demand
Elevata richiesta
ITPYZCHIVASAMSUNG BIOEPIS NL B.V.1 Jan 2026not givenIncreased demand
Elevata richiesta
ITIMULDOSAACCORD HEALTHCARE, S.L.U.3 Jun 2026not givenManufacturing problem
Problemi produttivi
ESIMULDOSA 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 26 mlAccord Healthcare S.L.U.2 Jun 202630 Dec 2027Not stated
ESSTEQEYMA 45 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,5 mlCelltrion Healthcare Hungary Kft.7 Oct 202610 Jan 2027Not stated
BEUsymro 45 mg inj. sol. s.c. pre-filled syr. 0.5 mlGedeon Richter21 Apr 202621 Apr 2027Other
Other reason
BEUsymro 90 mg inj. sol. s.c. pre-filled syr. 1 mlGedeon Richter21 Apr 202621 Apr 2027Other
Other reason
BEImuldosa 130 mg inf. sol. (conc.) i.v. vial 26 mlAccord Healthcare28 May 202630 Nov 2026Other
Other reason
BEYesintek 90 mg inj. sol. s.c. pre-filled pen 1 mlBiosimilar Collaborations Ireland1 Oct 2026not givenManufacturing problem
Delay in production

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply

Basiliximab Secukinumab Spesolimab Tocilizumab